why 1Life Healthcare Inc. [ONEM] is a Good Choice for Investors After New Price Target of $33.25

Must read

1Life Healthcare Inc. [NASDAQ: ONEM] gained 0.80% or 0.24 points to close at $30.25 with a heavy trading volume of 2170737 shares. The company report on July 20, 2020 that 1Life Healthcare (One Medical) Announces Date of its Second Quarter 2020 Results Conference Call.

1Life Healthcare, Inc. (One Medical) (Nasdaq: ONEM) today announced that its second quarter 2020 results will be released on Wednesday, August 12, 2020, after the close of the market. The company will host a conference call on the same day at 2:00 p.m. (PT) / 5:00 p.m. (ET) to discuss its financial results.

A live audio webcast will be available online at https://investor.onemedical.com. The conference call can also be accessed by dialing 1-800-258-1651 for U.S. participants, or 1-612-979-9928 for international participants, and referencing conference ID 3165554. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

It opened the trading session at $30.35, the shares rose to $31.97 and dropped to $29.76, the range by which the price of stock traded the whole day. The daily chart for ONEM points out that the company has recorded 27.15% gains over the past six months. However, it is still -101.67% lower than its most recent low trading price.

If we look at the average trading volume of 1.57M shares, ONEM reached to a volume of 2170737 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about 1Life Healthcare Inc. [ONEM]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ONEM shares is $33.25 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ONEM stock is a recommendation set at 2.20. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

SVB Leerink have made an estimate for 1Life Healthcare Inc. shares, keeping their opinion on the stock as Mkt Perform, with their previous recommendation back on July 01, 2020. The new note on the price target was released on June 19, 2020, representing the official price target for 1Life Healthcare Inc. stock.

The Average True Range (ATR) for 1Life Healthcare Inc. is set at 2.46, with the Price to Sales ratio for ONEM stock in the period of the last 12 months amounting to 13.69. The Price to Book ratio for the last quarter was 7.96, with the Price to Cash per share for the same quarter was set at 2.84.

Trading performance analysis for ONEM stock

1Life Healthcare Inc. [ONEM] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -9.81. With this latest performance, ONEM shares dropped by -19.40% in over the last four-week period, additionally plugging by 27.15% over the last 6 months .

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ONEM stock in for the last two-week period is set at 35.70, with the RSI for the last a single of trading hit 28.72, and the three-weeks RSI is set at 41.57 for 1Life Healthcare Inc. [ONEM]. The present Moving Average for the last 50 days of trading for this stock 34.38, while it was recorded at 30.29 for the last single week of trading.

1Life Healthcare Inc. [ONEM]: A deeper dive into fundamental analysis

Operating Margin for any stock indicates how profitable investing would be, and 1Life Healthcare Inc. [ONEM] shares currently have an operating margin of -19.59 and a Gross Margin at +34.16. 1Life Healthcare Inc.’s Net Margin is presently recorded at -19.02.

Return on Total Capital for ONEM is now -17.54, given the latest momentum, and Return on Invested Capital for the company is -17.84. Return on Equity for this stock declined to -22.58, with Return on Assets sitting at -13.95. When it comes to the capital structure of this company, 1Life Healthcare Inc. [ONEM] has a Total Debt to Total Equity ratio set at 63.39. Additionally, ONEM Total Debt to Total Capital is recorded at 38.80, with Total Debt to Total Assets ending up at 31.97.

Reflecting on the efficiency of the workforce at the company, 1Life Healthcare Inc. [ONEM] managed to generate an average of -$30,914 per employee. Receivables Turnover for the company is 11.75 with a Total Asset Turnover recorded at a value of 0.73.1Life Healthcare Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.80 and a Current Ratio set at 4.80.

1Life Healthcare Inc. [ONEM]: An earnings per share (EPS) analysis

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ONEM. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for 1Life Healthcare Inc. go to 27.00%.

An analysis of insider ownership at 1Life Healthcare Inc. [ONEM]

There are presently around $1,964 million, or 84.00% of ONEM stock, in the hands of institutional investors. The top three institutional holders of ONEM stocks are: CARLYLE GROUP INC. with ownership of 28,157,681, which is approximately New of the company’s market cap and around 4.30% of the total institutional ownership; FMR LLC, holding 9,509,562 shares of the stock with an approximate value of $287.66 million in ONEM stocks shares; and MAVERICK CAPITAL LTD, currently with $180.14 million in ONEM stock with ownership of nearly New of the company’s market capitalization.

Positions in 1Life Healthcare Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 90 institutional holders increased their position in 1Life Healthcare Inc. [NASDAQ:ONEM] by around 64,729,595 shares. Additionally, 5 investors decreased positions by around 520,590 shares, while 5 investors held positions by with 321,542 shares. The mentioned changes placed institutional holdings at 64,928,643 shares, according to the latest SEC report filing. ONEM stock had 87 new institutional investments in for a total of 64,653,493 shares, while 1 institutional investors sold positions of 244,667 shares during the same period.

Share on facebook
Share on twitter
Share on linkedin
Share on skype
Share on reddit

Leave a Comment

Your email address will not be published. Required fields are marked *



Download Free eBook For


100% free. stop anytime no spam



Download Free eBook For


100% free. stop anytime no spam